P E Thorpe
- Biotechnology top 0.5%
- Transgenic Plants and Applications 20
- Immunology top 2%
- Toxin Mechanisms and Immunotoxins 31
-
- Monoclonal and Polyclonal Antibodies Research 11
- Cancer Research top 10%
- Molecular Biology top 10%
- Angiogenesis and VEGF in Cancer 5
- Plant tissue culture and regeneration 5
- Glycosylation and Glycoproteins Research 3
-
- CAR-T cell therapy research 5
- Vascular Tumors and Angiosarcomas 3
- Co-authors
- Francis BurrowsRolf A. BrekkenA.J. CumberD C BlakeyW. C. J. RossBrian M. J. FoxwellP.P. KnowlesA N Brown
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
P E Thorpe
48 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 107
- Biotechnology 672
- Immunology 951
- Radiology, Nuclear Medicine and Imaging 466
- Cancer Research 222
- Molecular Biology 904
Countries citing papers authored by P E Thorpe
This map shows the geographic impact of P E Thorpe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P E Thorpe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P E Thorpe more than expected).
Fields of papers citing papers by P E Thorpe
This network shows the impact of papers produced by P E Thorpe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P E Thorpe. The network helps show where P E Thorpe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P E Thorpe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2010 | 9 | |
| 3 | 2006 | 26 | |
| 4 | 2005 | 44 | |
| 5 | 2004 | 16 | |
| 6 | 2002 | 7 | |
| 7 | 2001 | 39 | |
| 8 | Targeting of tumor vasculature | 1997 | 2 |
| 9 | 1994 | 32 | |
| 10 | Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice. | 1993 | 45 |
| 11 | [Immunotoxin: from the idea of "magic bullets" to clinical applications]. | 1990 | 1 |
| 12 | 1988 | 14 | |
| 13 | 1988 | 2 | |
| 14 | 1988 | 15 | |
| 15 | 1987 | 37 | |
| 16 | 1986 | 91 | |
| 17 | Intra-articular triamcinolone acetonide and methylprednisolone acetate in arthritis | 1985 | 10 |
| 18 | 1983 | 4 | |
| 19 | Elimination of leukaemic cells from rodent bone marrow in vitro with antibody-ricin conjugates: Implications for autologous marrow transplantation in man | 1982 | 7 |
| 20 | 1957 | 0 |
About P E Thorpe
P E Thorpe is a scholar working on Biotechnology, Immunology, Toxicology, Radiology, Nuclear Medicine and Imaging and Human Factors and Ergonomics, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (31 papers), Transgenic Plants and Applications (20 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), CAR-T cell therapy research (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Plant tissue culture and regeneration (5 papers), Glycosylation and Glycoproteins Research (3 papers) and Vascular Tumors and Angiosarcomas (3 papers). The work is most often cited by research in Biotechnology (672 citations), Immunology (951 citations), Radiology, Nuclear Medicine and Imaging (466 citations), Cancer Research (222 citations) and Molecular Biology (904 citations). P E Thorpe has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Francis Burrows, Rolf A. Brekken, A.J. Cumber, D C Blakey, W. C. J. Ross, Brian M. J. Foxwell, P.P. Knowles, A N Brown, G Watson and J.A. Forrester. Their work appears in journals such as British Journal of Cancer, Blood, Nature, Journal of Controlled Release and Biochimica et Biophysica Acta (BBA) - General Subjects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.